1-methyl-1,2,3,4-tetrahydroisoquinoline has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Mitsuo, Y; Mizuno, Y; Nagatsu, T; Suzuki, K; Yamauchi, Y | 1 |
| Hirobe, M; Makino, Y; Ohta, S; Tasaki, Y | 1 |
| Maruyama, W; Matsubara, K; Naoi, M; Ota, M; Takahashi, T | 1 |
| Dostert, P; Nagatsu, T; Naoi, M; Niwa, T; Takeda, N; Tatematsu, A; Yoshida, M; Yoshizumi, H | 1 |
| Absi, E; Ayala, A; Cano, J; Castaño, A; Machado, A; Parrado, J | 1 |
| Abe, K; Ishiwata, K; Kawamura, K; Koyanagi, Y; Saitoh, T; Sano, T; Senda, M; Taguchi, K; Toda, J | 1 |
| Kotake, Y; Ohta, S; Okuda, K | 1 |
| Abe, K; Chiba, T; Ishikawa, R; Kambe, T; Munakata, H; Saitoh, T; Taguchi, K | 1 |
8 other study(ies) available for 1-methyl-1,2,3,4-tetrahydroisoquinoline and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Selective inhibition of complex I by N-methylisoquinolinium ion and N-methyl-1,2,3,4-tetrahydroisoquinoline in isolated mitochondria prepared from mouse brain.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Dopamine Agents; Electron Transport; In Vitro Techniques; Isoquinolines; Mice; Mice, Inbred C57BL; Mitochondria; NAD(P)H Dehydrogenase (Quinone); Tetrahydroisoquinolines | 1992 |
1-Methyl-1,2,3,4-tetrahydroisoquinoline, decreasing in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, prevents parkinsonism-like behavior abnormalities.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Brain Chemistry; Isoquinolines; Male; Mice; Mice, Inbred C57BL; Motor Activity; Parkinson Disease; Rats; Tetrahydroisoquinolines; Time Factors | 1991 |
Structural studies of condensation products of biogenic amines as inhibitors of tryptophan hydroxylase.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Biogenic Amines; Brain; Dopamine; Isoquinolines; Kinetics; Male; Rats; Rats, Wistar; Structure-Activity Relationship; Tetrahydroisoquinolines; Tryptophan; Tryptophan Hydroxylase | 1994 |
Presence of tetrahydroisoquinoline-related compounds, possible MPTP-like neurotoxins, in parkinsonian brain.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Biotransformation; Culture Techniques; Dopamine; Frontal Lobe; Gas Chromatography-Mass Spectrometry; Humans; Isoquinolines; Neurotoxins; Parkinson Disease; Structure-Activity Relationship; Tetrahydroisoquinolines | 1993 |
The endogenous amine 1-methyl-1,2,3,4- tetrahydroisoquinoline prevents the inhibition of complex I of the respiratory chain produced by MPP(+).
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Antioxidants; Brain; Corpus Striatum; Electron Transport Complex I; Isoquinolines; Male; Mitochondria; Mitochondria, Liver; NADH, NADPH Oxidoreductases; Oxygen Consumption; Rats; Rats, Wistar; Synaptosomes; Tetrahydroisoquinolines; Tyrosine 3-Monooxygenase | 2000 |
Evaluation of neurotoxicity of TIQ and MPTP and of parkinsonism-preventing effect of 1-MeTIQ by in vivo measurement of pre-synaptic dopamine transporters and post-synaptic dopamine D(2) receptors in the mouse striatum.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Binding, Competitive; Corpus Striatum; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Hypokinesia; Isoquinolines; Ligands; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Parkinsonian Disorders; Radioligand Assay; Receptors, Dopamine D2; Stereoisomerism; Substantia Nigra; Synapses; Tetrahydroisoquinolines; Tyrosine 3-Monooxygenase; Up-Regulation | 2001 |
Parkinsonism-preventing activity of 1-methyl-1,2,3,4-tetrahydroisoquinoline derivatives in C57BL mouse in vivo.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Brain; Dopamine; Dopamine Antagonists; Mice; Mice, Inbred C57BL; Parkinsonian Disorders; Tetrahydroisoquinolines | 2006 |
Preventative effects of 1-methyl-1,2,3,4-tetrahydroisoquinoline derivatives (
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Humans; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neuroprotective Agents; Parkinsonian Disorders; Tetrahydroisoquinolines | 2022 |